XJPX7129
Market cap17mUSD
Dec 30, Last price
1,094.00JPY
1D
1.77%
1Q
-0.36%
IPO
-21.86%
Name
Miahelsa Holdings Corp
Chart & Performance
P/E
492.23
P/S
0.12
EPS
2.22
Div Yield, %
2.75%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
22.72b
+2.13%
Net income
6m
-97.36%
CFO
1.59b
+56.12%
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 12, 2025
Profile
Miahelsa Holdings Corporation engages in the operation of pharmaceutical, childcare, and nursing care businesses in Japan. The company operates dispensing pharmacies and provides home infusion therapy services. It also provides various nursing care services comprising in home care support, home-visit care, outpatient care, cohabitation care for dementia, home-visit nursing, visit bathing, small-scale multifunctional home care, support center, elderly welfare center, elderly with services homes for the elderly, and paid nursing homes with nursing care. In addition, the company operates health up center, welfare schools, nursery schools, and after school clubs. Further, the company is involved in the wholesale of food ingredients for school lunch; and provision of meal delivery services. Miahelsa Holdings Corporation was founded in 1966 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | |
| Income | |||
Revenues | 22,722,736 2.13% | 22,249,391 14.04% | 19,510,261 |
Cost of revenue | 22,327,044 | 22,057,450 | 19,323,570 |
Unusual Expense (Income) | |||
NOPBT | 395,692 | 191,941 | 186,691 |
NOPBT Margin | 1.74% | 0.86% | 0.96% |
Operating Taxes | 58,036 | 138,310 | 242,332 |
Tax Rate | 14.67% | 72.06% | 129.80% |
NOPAT | 337,656 | 53,631 | (55,641) |
Net income | 5,531 -97.36% | 209,580 -28.12% | 291,566 |
Dividends | (74,891) | (74,579) | (69,351) |
Dividend yield | 2.82% | 2.95% | 2.76% |
Proceeds from repurchase of equity | 36,020 | 140 | 4,632 |
BB yield | -1.36% | -0.01% | -0.18% |
| Debt | |||
Debt current | 2,524,931 | 2,775,598 | 2,456,296 |
Long-term debt | 2,185,798 | 2,539,272 | 3,168,714 |
Deferred revenue | 1,028,594 | 1,218,573 | |
Other long-term liabilities | 1,109,345 | 239,467 | 88,696 |
Net debt | 2,642,284 | 2,710,895 | 3,080,205 |
| Cash flow | |||
Cash from operating activities | 1,594,470 | 1,021,308 | 918,914 |
CAPEX | (302,411) | (539,319) | (922,126) |
Cash from investing activities | (336,079) | (556,761) | (2,534,428) |
Cash from financing activities | (610,324) | (368,673) | 2,011,347 |
FCF | 903,925 | 147,072 | |
| Balance | |||
Cash | 1,898,894 | 1,265,326 | 1,122,652 |
Long term investments | 169,551 | 1,338,649 | 1,422,153 |
Excess cash | 932,308 | 1,491,505 | 1,569,292 |
Stockholders' equity | 2,770,428 | 2,821,113 | 2,686,115 |
Invested Capital | 7,891,626 | 8,036,702 | 8,175,296 |
ROIC | 4.24% | 0.66% | |
ROCE | 4.17% | 1.87% | 1.78% |
| EV | |||
Common stock shares outstanding | 2,518 | 2,500 | 2,500 |
Price | 1,055.00 4.25% | 1,012.00 0.60% | 1,006.00 |
Market cap | 2,656,911 5.03% | 2,529,758 0.57% | 2,515,354 |
EV | 5,299,195 | 5,240,653 | 5,595,559 |
EBITDA | 1,049,974 | 835,686 | 711,070 |
EV/EBITDA | 5.05 | 6.27 | 7.87 |
Interest | 30,838 | 35,236 | 27,630 |
Interest/NOPBT | 7.79% | 18.36% | 14.80% |